SHAPEIT2 drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (4)
Papers in which this entity is mentioned.
- Genome-wide admixture mapping of DSM-IV alcohol dependence, criterion count, and the self-rating of the effects of ethanol in African American populations. (2021)
- Rare variant phasing using paired tumor:normal sequence data. (2019)
- Mapping and phasing of structural variation in patient genomes using nanopore sequencing. (2017)
- Reference-based phasing using the Haplotype Reference Consortium panel. (2016)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| shapeit2 | drug | 8 | 41 |
| shapeit | drug | 7 | 8 |
| shapeit v2 (r790) | drug | — | — |